BackPathfinder Cell Therapy Overview

Pathfinder Cell Therapy Current Cash

Pathfinder Cell Therapy's current cash is $4K.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$4000.00
82.61% YoYΔ $-19000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Pathfinder Cell Therapy Current Cash History

Loading

Pathfinder Cell Therapy vs. peers: Current Cash Comparison

Loading

Pathfinder Cell Therapy Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Pathfinder Cell Therapy (PFND) FAQ

As of the most recent data (September 2015), PFND shows a current cash of $4K. That compares with $23K in the prior-year period — down 82.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PFND's current cash is now $4K (was $23K) — a 82.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Pathfinder Cell Therapy is outperforming or lagging.

Tracking PFND's current cash over time shows whether Pathfinder Cell Therapy is scaling, shrinking, or reshaping that part of the business. The current reading is $4K That compares with $23K in the prior-year period — down 82.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Pathfinder Cell Therapy's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $4K) with ownership activity and broader fundamentals.

Pathfinder Cell Therapy's current cash is $4K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.